№ files_lp_4_process_2_45758
File format: docx
Character count: 2875
File size: 56 KB
Provides detailed guidelines and rules for submitting and organizing Investigators Workshops proposals for the 2026 AES Annual Meeting, including participant roles, deadlines, and submission procedures.
Year:
2026
Event:
AES Annual Meeting
Location:
Denver, CO, USA
Document Type:
Proposal Guidelines / FAQs
Audience:
Investigators and workshop moderators
Submission Deadline:
January 13, 2026, 12PM PT
Roles Defined:
Moderator, Co-Moderator, Speaker, Young Investigator Speaker
Maximum Faculty Participants:
5
Young Investigator Definition:
Within 5 years post-training
Submission Method:
Online submission system
Notification of Acceptance:
Mid-March 2026
Registration Requirement:
Required for all accepted faculty
Travel Support:
Available for non-member speakers with $500 honorarium
Contact:
[email protected], Phone: (312) 883-3800
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Region / City:
Dayton Zone
Topic:
Transmission Revenue Requirements
Document Type:
Annual Update
Organization:
The Dayton Power and Light Company d/b/a AES Ohio
Author:
AES Ohio
Target Audience:
Interested Parties, PJM stakeholders
Period of Action:
2025-2026
Approval Date:
October 1, 2025
Date of Changes:
October 1, 2025
Year:
2022
Date:
06/04/2022
Document type:
Design document
Project:
AES Phase 1
Subject area:
Customs export systems
Institution:
European Commission
Directorate-General:
Directorate-General for Taxation and Customs Union (DG TAXUD)
Author:
CUST-DEV3
Approved by:
DG TAXUD
Project owner:
DG TAXUD Unit B1 Process and Data, Customer Relationship and Planning
Solution provider:
DG TAXUD Unit B3 Customs Systems
Release and version:
5.15.0-v1.00 EN
Status:
Submitted for acceptance (SfA)
Reference number:
DLV-579-6-49-1-3
Confidentiality:
Publicly available (PA)
Framework contract:
TAXUD/2013/CC/124
Specific contract:
SC35
Intended audience:
National Administrations and DG TAXUD stakeholders
Language:
English
Year:
2022
Region / City:
Vici
Theme:
Research support
Document type:
Letter of support
Organization / Institution:
[company name]
Author:
[author name]
Target audience:
Research organizations, project proposers
Period of validity:
Not specified
Date of approval:
Not specified
Date of amendments:
Not specified
Year:
2015
Publisher:
E-Stats Publishing
Subject:
Economics / Income Distribution
Document Type:
Assessment / Test
Target Audience:
Students
Time Allowed:
30 minutes
Location:
Australia
Author:
E-Stats Publishing
Related Topics:
Lorenz Curve, Gini Coefficient, Taxation, Income Inequality
Scoring:
Multiple Choice and Short Answer Questions
Reference Period:
2015
Copyright:
E-Stats Publishing 2015
Year:
Not specified
Region / City:
Not specified
Topic:
Long-term care, Medicaid, SSDI, Employment
Document type:
Proposal
Agency / Institution:
Not specified
Author:
Not specified
Target audience:
Not specified
Period of validity:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Note:
Contextual description
Year:
2026
Region / City:
Goa, India
Topic:
AES 256-bit Specification
Document Type:
Change Request
Organization / Institution:
3GPP
Author:
Nokia
Target Audience:
3GPP Working Group members
Period of Effect:
Rel-20
Approval Date:
2026-01-26
Modification Date:
N/A
Year:
2026
Region / city:
Westville Campus, UKZN
Field:
Education, Academic Support
Document Type:
Job Vacancy Announcement
Institution:
College of Agriculture, Engineering and Science, UKZN
Author:
Unknown
Target Audience:
Postgraduate students, potential SI Coordinators
Period of validity:
2024 Semester 1
Approval Date:
Not specified
Date of Changes:
Not specified
Document type:
Application form
Regulatory authority:
South African Health Products Regulatory Authority (SAHPRA)
Country:
South Africa
Subject:
Additions and/or changes in investigators and clinical trial sites
Document number:
GLF-CEM-CT-01D
Related form:
CTF3
Version:
v4
Date of first approval:
October 2019
Date of latest update:
September 2022
Update history:
October 2019 first version approved; March 2020 administrative changes; September 2022 administrative changes, checklist update, appendix removal, document number change
Applicable actions:
Additional investigator(s); Change of investigator(s); Additional site(s); Change in site location
Required attachments:
Cover letter; Investigator documents; Site staff documents; Proof of payment
Approval bodies referenced:
Ethics Committee(s)
Intended applicant:
Sponsor, CRO, or local sponsor company
Regulated area:
Clinical trials
Note:
Year
Topic:
Financial Disclosure
Document Type:
Form
Organization / Institution:
Study Sponsor
Target Audience:
Clinical Investigators, Sub-Investigators
Year:
2024
Region / City:
USA
Topic:
Clinical Research, Regulatory Compliance
Document Type:
Guidance Document
Author:
OVPRI Regulatory Affairs
Target Audience:
Principal Investigators, Research Administrators, Clinical Research Coordinators
Period of Effectiveness:
N/A
Approval Date:
04/25/2024
Amendment Date:
07/09/2024
Description:
Guidance document detailing the steps and regulatory requirements for transferring clinical studies between principal investigators, including documentation updates and approvals required for drug, device, and investigator-initiated studies.
Issuing organization:
National Institutes of Health
Program:
Maximizing Investigators’ Research Award for Early Stage Investigators
Funding mechanism:
R35
Clinical trial policy:
Clinical Trial Optional
Document type:
Application guidance and checklist
Subject area:
Biomedical and behavioral research funding
Target applicants:
Early Stage Investigators
Related documents:
Funding Opportunity Announcement; SF424 (R&R) Research Instructions
Application components:
Forms, narrative attachments, budgets, human subjects and clinical trials information
Formatting requirements:
Font, margins, layout, and hyperlink rules specified
Jurisdiction:
United States
Year:
2023
Region / City:
USA
Subject:
Clinical Research, Financial Disclosure
Document Type:
Form
Organization / Institution:
FDA
Author:
FDA
Target Audience:
Clinical investigators
Effective Period:
Ongoing
Approval Date:
N/A
Date of Changes:
N/A
Year:
2016
Region / city:
Not specified
Subject:
Clinical trial regulations, GCP compliance
Document type:
Checklist
Institution:
Not specified
Author:
Not specified
Target audience:
Investigators, trial staff
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2023
Region / city:
N/A
Topic:
Clinical Trial Consent
Document Type:
Research Protocol
Organization / Institution:
DF/HCC
Author:
N/A
Target Audience:
Parents or Guardians of Children Participating in Clinical Trials
Effective Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
November 2023
Region / City:
London
Topic:
Research Funding
Document Type:
Policy
Organization:
British Heart Foundation
Author:
British Heart Foundation
Target Audience:
Principal Investigators, Co-applicants, Research Staff
Period of Application:
Until 3 months after the grant end date
Approval Date:
November 2023
Date of Changes:
N/A
Year:
2022
Region / City:
London
Topic:
Clinical Trials, Investigational Medicinal Products, Clinical Development
Document Type:
Template
Organization / Institution:
University College London
Author:
University College London
Target Audience:
Clinical researchers, Investigators, Medical professionals involved in Clinical Trials
Effective Date:
02-Mar-2022
Version:
2.0
Period of Validity:
Reviewed annually
Approval Date:
02-Mar-2022
Date of Last Revision:
Not specified
Year:
20XX
Region / City:
Durham, NC
Theme:
Clinical Trials, Investigational Drugs
Organization / Institution:
Duke University
Author:
Not specified
Target Audience:
Investigators, Institutional Review Boards, Ethics Committees
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Note:
Year
Topic:
Financial disclosure, clinical study
Document Type:
Form
Target Audience:
Investigators, Sub-Investigators, Clinical Research Participants